| S0185 |
BMS-5
|
BMS-5 (LIMKi 3) is a potent inhibitor of LIM kinases (LIMK) with IC50 of 7 nM and 8 nM for LIMK1 and LIMK2, respectively.
|
-
Adv Sci (Weinh), 2025, 12(29):e03223
-
Leukemia, 2025, 10.1038/s41375-025-02729-w
|
|
| S6498 |
T56-LIMKi
|
T56-LIMKi is a selective inhibitor of LIMK2.
|
|
|
| S6837 |
R-10015
|
R-10015 is a potent, selective inhibitor of LIM domain kinase (LIMK) with IC50 of 38 nM for human LIMK1. This compound binds to the ATP-binding pocket and acts as a broad-spectrum antiviral compound for HIV infection.
|
|
|
| S6836 |
TH-257
|
TH-257 is a potent and exquisitely selective LIM kinase (LIMK) inhibitor with IC50 of 84 nM and 39 nM for LIMK1 and LIMK2, respectively.
|
|
|
| E1724 |
CRT-0105446
|
CRT 0105446 (compound 22d) is a potent inhibitor of LIMK1 with an IC50 of 8 nM. It can inhibit the growth of MCF-7 breast cancer cells and the invasion of MDA-MB-231 cells by reducing the expression of phosphorylated cofilin.
|
|
|